Healthcare Sales & Marketing Network News: cardiomyopathy

Searching News Database: cardiomyopathy

HSMN NewsFeed - 24 Jan 2025
Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors
Regenerative Medicine Cardiology Personnel

HSMN NewsFeed - 12 Dec 2024
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Devices Cardiology FDA

HSMN NewsFeed - 18 Sep 2024
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of 420mg Strength of HERCESSI(TM) (trastuzumab-strf), a biosimilar to Herceptin(R) (trastuzumab), for the Treatment of Several Forms of HER2-Overexpressing Cancer
Biopharmaceuticals Generics Oncology FDA

HSMN NewsFeed - 22 May 2023
Corvia Medical Releases Two-Year Clinical Trial Results Confirming Sustained Benefit and Safety of its Atrial Shunt in Heart Failure Patients
Devices Interventional Cardiology

HSMN NewsFeed - 17 Oct 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Devices Cardiology FDA

HSMN NewsFeed - 1 Apr 2022
Reduce LAP-HF II Analyses Show 50% of Study Patients Demonstrated Significant Clinical Benefit from the Corvia(R) Atrial Shunt
Devices Interventional Cardiology

HSMN NewsFeed - 18 Jun 2021
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 3 Mar 2020
FDA Grants Rare Pediatric Disease Designation to Stealth BioTherapeutics for Elamipretide for the Treatment of Barth Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Dec 2019
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Sep 2019
BioVentrix Announces the Appointment of Pedro Marques as VP of Sales in Europe
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 6 Aug 2019
BioVentrix Announces Key Additions to Leadership Team
Devices Cardiology Personnel

HSMN NewsFeed - 31 Jul 2019
REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich's Ataxia Using NAV(R) AAV9 Vector
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 25 Jul 2019
U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 24 Jun 2019
Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 1 Oct 2018
FDA Approves KYPROLIS(R) (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 7 Aug 2018
Array BioPharma Receives FDA Breakthrough Therapy Designation for BRAFTOVI(TM) in combination with MEKTOVI(R) and cetuximab for BRAFV600E-mutant Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Jul 2018
The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI(TM) (encorafenib) in Combination with MEKTOVI(R) (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Jul 2018
New England Journal of Medicine Publishes Results from Pivotal Study of TEGSEDI(TM) (inotersen) for the Treatment of Hereditary ATTR Amyloidosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 May 2018
Abbott's Investigational Tendyne(TM) Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study
Devices Interventional Cardiology

HSMN NewsFeed - 17 May 2018
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess(R) in China
Biopharmaceuticals Cardiology

HSMN NewsFeed - 17 Apr 2018
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess(R)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Apr 2018
Eidos Therapeutics completes $64M Series B financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 Mar 2018
Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
Devices Cardiology Personnel

HSMN NewsFeed - 15 Mar 2018
Ionis and Akcea Partner to Commercialize Inotersen for hATTR
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Feb 2018
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
Devices Cardiology FDA

HSMN NewsFeed - 12 Feb 2018
Ferring's CLENPIQ(TM) (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep Now Available
Biopharmaceuticals Gastroenterology Product Launch

HSMN NewsFeed - 30 Jan 2018
FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jan 2018
MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 1 Dec 2017
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 9 Nov 2017
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Oct 2017
SutroVax Appoints Veteran Vaccine Experts to Executive Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2017
Capricor Therapeutics Presents Positive Six-Month Results in Duchenne Muscular Dystrophy at World Muscle Society International Congress
Regenerative Medicine

HSMN NewsFeed - 4 Oct 2017
BioVentrix Announces First Patient Enrolled in the U.S. arm of IDE Study of the Revivent TC(TM) TransCatheter Ventricular Enhancement Treatment
Devices Interventional Cardiology

HSMN NewsFeed - 18 Sep 2017
BioVentrix announces the 1st Revivent TC(TM) TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment at the University Heart Center Zurich in Switzerland
Devices Interventional Cardiology

HSMN NewsFeed - 21 Aug 2017
Cardiome Provides U.S. Regulatory Update For BRINAVESS
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 21 Aug 2017
BioVentrix Announces First Patient Enrolled in IDE Study of the Revivent TC(TM) TransCatheter Ventricular Enhancement Treatment for Ischemic Cardiomyopathy
Devices Cardiology

HSMN NewsFeed - 12 Jun 2017
Cardiome Announces Commercial Launch of BRINAVESS(R) (Vernakalant Hydrochloride) in Canada
Biopharmaceuticals Cardiology Product Launch

HSMN NewsFeed - 10 Apr 2017
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Regenerative Medicine Personnel

HSMN NewsFeed - 13 Mar 2017
BioVentrix announces the 1st Revivent TC(TM) TransCatheter commercial procedure to treat Ischemic Cardiomyopathy in China
Devices Cardiology

HSMN NewsFeed - 6 Feb 2017
BioVentrix Announces NUB Reimbursement Status 1 for Revivent TC(TM) TransCatheter Ventricular Enhancement System in Germany
Devices Interventional Cardiology Reimbursement

HSMN NewsFeed - 19 Dec 2016
BioVentrix Announces the 1st Revivent TC(TM) TransCatheter Ventricular Enhancement Procedure in Germany After Receiving CE-Mark Certification
Devices Interventional Cardiology

HSMN NewsFeed - 10 Oct 2016
First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT(R) (sunitinib) Extended Disease Free Survival After Surgical Removal
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Oct 2016
Steven Healy appointed as Chairman of the Board of Directors of BioVentrix, Inc.
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 9 Sep 2016
Berlin Heals Announces Closure of Second Round Funding for Novel Cardiac Microcurrent System
Devices Cardiology Venture Capital

HSMN NewsFeed - 7 Sep 2016
FDA allows Phrixus’s IND for Carmeseal-MD(TM) (P-188 NF) in Duchenne muscular dystrophy (DMD)
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Jul 2016
European Commission Approves Extended Indication For Amgen's Kyprolis(R) (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 31 May 2016
BioVentrix receives FDA IDE Approval for its Pivotal Clinical Trial, ALIVE
Devices Interventional Cardiology FDA

HSMN NewsFeed - 7 Apr 2016
PhaseBio Announces Leadership Team Appointments
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 15 Mar 2016
Heart Metabolics Announces Multiple Senior Appointments To Management Team
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 17 Feb 2016
Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Aug 2014
FDA Approves Boehringer Ingelheim's Striverdi(R) Respimat(R) (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jun 2014
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
Regenerative Medicine

HSMN NewsFeed - 15 May 2014
Sorbent Therapeutics Closes First Tranche Of $15 Million Series D Financing
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 17 Apr 2014
Heart Metabolics Limited Launched in Ireland with $20 Million Series A Financing
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 8 Apr 2014
Mitralign Completes Enrollment in EU Study for its Novel Catheter-based Valve Repair Device
Devices Interventional Cardiology

HSMN NewsFeed - 7 Feb 2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 13 Jan 2014
Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing

HSMN NewsFeed - 30 Oct 2013
MyoKardia Appoints Tassos Gianakakos to Chief Executive Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 9 May 2013
Ochsner Medical Center Implants 1st SynCardia Total Artificial Heart in Gulf South Region
Devices Cardiology

HSMN NewsFeed - 18 Apr 2013
Nebraska Medical Center Implants State's First SynCardia Total Artificial Heart
Devices Cardiology

HSMN NewsFeed - 30 Jan 2013
MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 20 Sep 2012
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
Personalized Medicine Cardiology Venture Capital

HSMN NewsFeed - 18 May 2012
CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Devices Interventional Cardiology

HSMN NewsFeed - 29 Mar 2012
University of Washington Medical Center 1st in Pacific Northwest to Discharge a Patient Without a Human Heart
Devices Cardiology

HSMN NewsFeed - 14 Mar 2012
Aastrom Biosciences Appoints Dr. LaVonne Lang as Head of Regulatory Affairs
Regenerative Medicine Personnel

HSMN NewsFeed - 28 Feb 2012
Bioheart Announces University of Miami as Clinical Site for ANGEL Trial of LipiCell(TM)
Regenerative Medicine Cardiology

HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Regenerative Medicine Cardiology

HSMN NewsFeed - 2 Dec 2011
Missouri Baptist Medical Center Physicians Are First in Missouri to Implant New Heart Failure Device
Devices Cardiology

HSMN NewsFeed - 10 Aug 2011
UK's 1st Total Artificial Heart Patient Discharged Home Using Freedom(R) Portable Driver
Devices Cardiology

HSMN NewsFeed - 31 Mar 2011
VICTRELIS(TM) (boceprevir), Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control
Biopharmaceuticals

HSMN NewsFeed - 28 Mar 2011
Medtronic Announces FDA Approval of Protecta(TM) Implantable Defibrillators That Reduce Inappropriate Shocks
Devices Cardiology FDA

HSMN NewsFeed - 22 Feb 2011
Published Data From e-HEALING Registry Demonstrate Good Clinical Outcomes With Low Incidence of Repeat Revascularization and Stent Thrombosis for OrbusNeich's Genous Stent
Devices Interventional Cardiology

HSMN NewsFeed - 18 Nov 2010
University Hospital of Nantes Presents 18-Year Experience with SynCardia’s Total Artificial Heart
Devices Cardiology

HSMN NewsFeed - 15 Nov 2010
Edwards SAPIEN Transcatheter Heart Valve Demonstrates Substantial Improvement in Quality of Life in Inoperable Patients
Devices Interventional Cardiology

HSMN NewsFeed - 12 Oct 2010
Italian Man Surpasses 1,000 Days of Support with SynCardia’s Total Artificial Heart
Devices Cardiology

HSMN NewsFeed - 2 Sep 2010
Cardiogenesis Comments on the STAR-Heart Study Presented at European Society of Cardiology (ESC) 2010 Congress
Regenerative Medicine Devices Cardiology

HSMN NewsFeed - 1 Sep 2010
Pfizer to Acquire FoldRx Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Aug 2010
TomTec Introduces A New Version of Its 2D CPA Software, an Open Solution for Strain and Time to Peak Velocity Analysis Based on Speckle Tracking
Devices Radiology Cardiology

HSMN NewsFeed - 17 Jun 2010
Medtronic Announces European Launch of Protecta Portfolio with SmartShock Technology Shown to Significantly Reduce Inappropriate Shocks
Devices Cardiology

HSMN NewsFeed - 17 Jun 2010
St. Jude Medical Announces First Enrollment in Landmark Clinical Trial of Novel Heart Failure Management System
Devices Monitoring Cardiology

HSMN NewsFeed - 8 Jun 2010
Scott C. Durbin Joins Aastrom as Chief Financial Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 25 May 2010
Abbott's Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
Devices Cardiology

HSMN NewsFeed - 20 May 2010
Aastrom Announces Senior Management Appointments
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 17 May 2010
First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy
Regenerative Medicine Interventional Cardiology

HSMN NewsFeed - 5 May 2010
FoldRx Pharmaceuticals Appoints Dr. Georges Gemayel as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Mar 2010
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
Regenerative Medicine Cardiology

HSMN NewsFeed - 24 Feb 2010
Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals

HSMN NewsFeed - 19 Jan 2010
WorldHeart Announces First U.S. Implant of Levacor(TM) VAD Implant at INTEGRIS in Oklahoma City
Devices Cardiology

HSMN NewsFeed - 22 Dec 2009
Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals

HSMN NewsFeed - 23 Nov 2009
ARCA Receives FDA Fast Track Designation for Gencaro(TM) Development in Genotype-Defined Heart Failure Population
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 11 Nov 2009
Texas Children's Hospital Achieves Pediatric Cardiology "First," Discharges Teen with Mechanical Heart Assist Device
Devices Cardiology

HSMN NewsFeed - 10 Nov 2009
500th Patient Receives an INCOR Ventricular Assist Device at the German Heart Institute Berlin
Devices Cardiology

HSMN NewsFeed - 5 Oct 2009
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Sep 2009
Aastrom Announces Transitions in Senior Management
Regenerative Medicine Personnel

HSMN NewsFeed - 9 Jun 2009
William Aliski Named FoldRx Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jun 2009
TomTec has received approval from the U.S. Food and Drug Administration (FDA) for its 2D CPA, a Vendor Independent Solution for Strain and Time to Peak Velocity Analysis Based on Speckle Tracking
Devices Cardiology FDA

HSMN NewsFeed - 28 May 2009
500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
Devices Cardiology

HSMN NewsFeed - 4 May 2009
SCAI Highlights Cardiac Dimensions Inc AMADEUS Study as an Important "Late Breaking" Clinical Trial
Devices Interventional Cardiology

HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Feb 2009
Cardiac Dimensions(R) Inc. Receives CE Mark for CARILLON Mitral Contour System
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 27 Jan 2009
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
Biopharmaceuticals

HSMN NewsFeed - 15 Jan 2009
Cleveland Clinic to Present Results from Study Using Ivivi Technologies' tPEMF(tm) on Cardiac Ischemia At American College of Cardiology Annual Meeting
Devices Cardiology

HSMN NewsFeed - 19 Sep 2008
Cardiac Dimensions(R), Inc. Announces Key Personnel Changes
Devices Cardiology

HSMN NewsFeed - 5 Aug 2008
NewCardio Names Ihor Gussak, M.D., Ph.D., FACC Chief Medical Officer
Devices Cardiology Personnel

HSMN NewsFeed - 8 Jul 2008
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Biopharmaceuticals

HSMN NewsFeed - 15 May 2008
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation
Biopharmaceuticals Cardiology

HSMN NewsFeed - 13 May 2008
St. Jude Medical Announces Start of Landmark DETERMINE ICD Study
Devices Cardiology

HSMN NewsFeed - 1 Apr 2008
Orqis(R) Medical's Cancion(R) System Significantly Increases Cardiac Performance
Devices Cardiology

HSMN NewsFeed - 25 Mar 2008
Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 12 Mar 2008
Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement
Regenerative Medicine Cardiology

HSMN NewsFeed - 18 Dec 2007
Cardiac Dimensions(R) Inc. Announces Closing of $35.5 Million Round of Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 7 Nov 2007
Advanced Cell Technology Announces 12-Month Results of Myoblast Therapy Trial
Regenerative Medicine Cardiology

HSMN NewsFeed - 18 Oct 2007
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
Regenerative Medicine Orthoapedic

HSMN NewsFeed - 4 Oct 2007
MicroMed Cardiovascular Announces First DeBakey VAD(R) Implant at the Bakoulev Institute in Moscow
Devices Cardiology

HSMN NewsFeed - 28 Sep 2007
Santhera Announces Start of US Phase III Clinical Trial with SNT-MC17 in Friedreich's Ataxia and Provides Details on Study Design
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 5 Sep 2007
The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
Biopharmaceuticals Cardiology

HSMN NewsFeed - 16 Aug 2007
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 29 Jun 2007
Ivivi Technologies Announces Completion of Patient Enrollment for its Cardiac Clinical Trial at The Cleveland Clinic Florida
Devices Cardiology

HSMN NewsFeed - 27 Jun 2007
First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
Regenerative Medicine

HSMN NewsFeed - 22 Jun 2007
FDA Approves Carnitor(R) SF (Levocarnitine) Sugar-Free Oral Solution For Patients With Carnitine Deficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Jun 2007
Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 May 2007
MicroMed Announces First Implant of the DeBakey VAD(R) X2 Design in the United Kingdom
Devices Cardiology

HSMN NewsFeed - 22 May 2007
Orqis(R) Medical's MOMENTUM Pivotal Trial Nears Enrollment Completion
Devices Cardiology

HSMN NewsFeed - 17 May 2007
Celladon and Targeted Genetics Initiate Phase I Clinical Trial of MYDICAR(TM) in Patients With Heart Failure
Regenerative Medicine Cardiology

HSMN NewsFeed - 7 May 2007
FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
Regenerative Medicine Orthopaedic

HSMN NewsFeed - 30 Apr 2007
Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
Regenerative Medicine FDA

HSMN NewsFeed - 26 Mar 2007
Largest Prospective Study of Microvolt T-Wave Alternans in Patients with Non-ischemic Cardiomyopathy Confirms the Predictive Value of MTWA
Devices Cardiology

HSMN NewsFeed - 15 Mar 2007
Data Highlighting Cambridge Heart's Non-Invasive HearTwave(R) II System to be Presented in Late Breaker at American College of Cardiology Meeting
Devices Cardiology

HSMN NewsFeed - 1 Feb 2007
Aastrom Receives Orphan Drug Designation from FDA for Dilated Cardiomyopathy
Regenerative Medicine Cardiology FDA

HSMN NewsFeed - 20 Nov 2006
Orqis(R) Medical Reaches MOMENTUM Pivotal Trial Mid-Point with 100th Patient Enrollment
Devices Cardiology

HSMN NewsFeed - 16 Nov 2006
Orqis(R) Medical Receives 13th U.S. Patent
Devices Cardiology

HSMN NewsFeed - 15 Nov 2006
Pharmion Acquires Cabrellis Pharmaceuticals, Gains Rights to Amrubicin for North America and the European Union
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 13 Nov 2006
WellPoint To Cover Microvolt T-Wave Alternans Testing
Devices Cardiology Reimbursement

HSMN NewsFeed - 13 Sep 2006
Vasogen's Celacade(TM) Shown to Significantly Reduce Time in Hospital in Prime Heart Failure Target Population
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Jul 2006
FDA Approves Abiomed's New Integrated Off-Pump Cannula
Devices Cardiology FDA

HSMN NewsFeed - 30 May 2006
FoldRx Pharmaceuticals Closes $43 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 May 2006
ABIOMED Announces French Regulatory Approval of the AB5000 Circulatory Support System
Devices Cardiology

HSMN NewsFeed - 8 May 2006
Largest US Study Confirms Predictive Ability of Microvolt T-Wave Alternans
Devices Cardiology

Return to NewsFeed

Additional items found! 55

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 55 additional stories matching:
cardiomyopathy
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.